Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07381049 · ClinicalTrials.gov registry record · NA
Effect of Cash Benefits on Health Care Spending
A NA study of Health Care Utilization and Health Care Costs, sponsored by Harvard Medical School (HMS and HSDM).
- Active
- Registry status
- NA
- Development phase
- 3,615
- Enrollment target
- 3
- Study locations
NCT07381049: Active NA study of Health Care Utilization and Health Care Costs, sponsored by Harvard Medical School (HMS and HSDM).
NCT07381049 is a NA study of Health Care Utilization and Health Care Costs that is active but no longer recruiting, run by Harvard Medical School (HMS and HSDM). The registered enrollment target is 3,615 participants, above the 777-participant average among 25 other Health Care Utilization trials with a reported enrollment target (365% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07381049, a NA study of Health Care Utilization and Health Care Costs, is active but no longer recruiting, sponsored by Harvard Medical School (HMS and HSDM).
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3,615 participants
- Enrollment target
- 3
- Study locations
Study Summary
During the first two years of the COVID-19 pandemic, the City of Chelsea, Massachusetts held a lottery to allocate monthly cash benefits to its residents. Using data from the Chelsea Eats program, the investigators propose to study the impact of the cash benefit on health care spending.
Primary Outcome
Total payments to providers for medical services
Conditions Studied
Interventions
- OTHER Cash Benefit
- OTHER No Cash Benefit
Study Locations (3)
Massachusetts
- Brigham and Women's Hospital / Harvard Medical School - Boston
- Harvard University - Cambridge
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,615 participants |
| Start Date | 2020-07-27 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT07381049 still lists
NCT07381049 is an interventional study that assigns participants to a tested intervention. Its 3,615 participants enrollment target places it among the larger protocols in the corpus, above the 777-participant average among 25 other Health Care Utilization trials with a reported enrollment target (365% higher).
The record links to 2 conditions, with Health Care Utilization appearing as the primary indexed condition, and to 2 interventions - of which Cash Benefit is the first listed.
NCT07381049 reports a single indexed study location in Massachusetts, Michigan.
Frequently Asked Questions
What is clinical trial NCT07381049 about?
NCT07381049 is a clinical study titled "Effect of Cash Benefits on Health Care Spending". During the first two years of the COVID-19 pandemic, the City of Chelsea, Massachusetts held a lottery to allocate monthly cash benefits to its residents. Using data from the Chelsea Eats program, the investigators propose to study the impact of the cash benefit on health care spending.
What is the current status of trial NCT07381049?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,615 participants. The study started on 2020-07-27. Estimated completion is 2026-12.
What conditions does trial NCT07381049 study?
This clinical trial studies the following conditions: Health Care Utilization, Health Care Costs.
What interventions are being tested in trial NCT07381049?
The interventions under investigation include: Cash Benefit (OTHER), No Cash Benefit (OTHER).
Who is sponsoring clinical trial NCT07381049?
This trial is sponsored by Harvard Medical School (HMS and HSDM), which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07381049 being conducted?
This trial has 3 study locations across Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Care Utilization
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07381049's enrollment target sits among peer trials
3,615 3rd of 25 higher than 23 of 25 other Health Care Utilization trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Health Care Utilization trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
UCSD RELINK: Connecting Adults To Supportive Services
RECRUITING · NA
-
ACP Video Intervention for Patients With Life-Limiting Illness
RECRUITING · NA
-
Evaluation of a Health System Integrated Model for Postpartum Education and Support in Rural Populations
RECRUITING · NA
-
Fresh RX: NHS 2020
RECRUITING · NA
-
Universal Basic Income and Structural Racism in the US South: HIV Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06354920 · 3,624 participants · NA
M-Well Bonding Bundle to Improve Patient-Physician Relationships
- NCT06088498 · 3,600 participants · Phase 2
App for Reducing Cravings to Smoke
- NCT06501118 · 3,600 participants · NA
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
- NCT06919419 · 3,600 participants · NA
HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI